Literature DB >> 22975585

Evidence for premature lipid raft aging in APP/PS1 double-transgenic mice, a model of familial Alzheimer disease.

Noemí Fabelo1, Virginia Martín, Raquel Marín, Gabriel Santpere, Ester Aso, Isidro Ferrer, Mario Díaz.   

Abstract

Altered lipid raft homeostasis has been considered to contribute to cellular deregulation, leading to neuronal loss in Alzheimer disease. Alterations in these microdomains affect amyloid precursor protein (APP) processing, resulting in neurotoxic conditions, but modifications of the molecular structure of lipid rafts in Alzheimer disease model mice have not been characterized. Using a lipidomic approach, we investigated frontal cortex lipid rafts inwild-type mice and in double-transgenic APP/presenilin 1 (PS1) mice. Lipid rafts in wild-type mice undergo age-dependent modifications, that is, decreased cholesterol and sterol esters levels, augmented sphingomyelin and saturated fatty acid content, and increased phospholipids/cholesterol ratio. These age-dependent changes were more dramatic and occurred earlier in APP/PS1 mice; other lipid classes (e.g. sulfatides) and essential long-chain polyunsaturated fatty acids (including docosahexaenoic and arachidonic acids) were also affected. Steady state anisotropy measurements demonstrated that APP/PS1 animals exhibit more viscous (membrane-ordered) lipid rafts and that this is mainly attributable to reduced unsaturation of phospholipids and increased sphingomyelin levels rather than to changes in cholesterol. In summary, we demonstrate that aging is accompanied by alteration of the physicochemical structure of lipid raft microdomains. This "lipid raft aging," a metaphenomenon, is considerably exacerbated by the induced amyloid burden in APP/PS1 genotype.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22975585     DOI: 10.1097/NEN.0b013e31826be03c

Source DB:  PubMed          Journal:  J Neuropathol Exp Neurol        ISSN: 0022-3069            Impact factor:   3.685


  30 in total

Review 1.  Peroxisomes of the Brain: Distribution, Functions, and Associated Diseases.

Authors:  Rachayeeta Deb; Neha Joshi; Shirisha Nagotu
Journal:  Neurotox Res       Date:  2021-01-05       Impact factor: 3.911

Review 2.  Central and Peripheral Metabolic Defects Contribute to the Pathogenesis of Alzheimer's Disease: Targeting Mitochondria for Diagnosis and Prevention.

Authors:  Yunhua Peng; Peipei Gao; Le Shi; Lei Chen; Jiankang Liu; Jiangang Long
Journal:  Antioxid Redox Signal       Date:  2020-03-16       Impact factor: 8.401

Review 3.  Lipid rafts in neurodegeneration and neuroprotection.

Authors:  Sandro Sonnino; Massimo Aureli; Sara Grassi; Laura Mauri; Simona Prioni; Alessandro Prinetti
Journal:  Mol Neurobiol       Date:  2013-12-22       Impact factor: 5.590

Review 4.  Interaction of membrane/lipid rafts with the cytoskeleton: impact on signaling and function: membrane/lipid rafts, mediators of cytoskeletal arrangement and cell signaling.

Authors:  Brian P Head; Hemal H Patel; Paul A Insel
Journal:  Biochim Biophys Acta       Date:  2013-07-27

Review 5.  Cholesterol in brain disease: sometimes determinant and frequently implicated.

Authors:  Mauricio G Martín; Frank Pfrieger; Carlos G Dotti
Journal:  EMBO Rep       Date:  2014-09-15       Impact factor: 8.807

Review 6.  From peroxisomal disorders to common neurodegenerative diseases - the role of ether phospholipids in the nervous system.

Authors:  Fabian Dorninger; Sonja Forss-Petter; Johannes Berger
Journal:  FEBS Lett       Date:  2017-09-07       Impact factor: 4.124

7.  Loss of parkin promotes lipid rafts-dependent endocytosis through accumulating caveolin-1: implications for Parkinson's disease.

Authors:  Seon-Heui Cha; Yu Ree Choi; Cheol-Ho Heo; Seo-Jun Kang; Eun-Hye Joe; Ilo Jou; Hwan-Myung Kim; Sang Myun Park
Journal:  Mol Neurodegener       Date:  2015-12-01       Impact factor: 14.195

8.  Genotype-induced changes in biophysical properties of frontal cortex lipid raft from APP/PS1 transgenic mice.

Authors:  Mario L Diaz; Noemí Fabelo; Raquel Marín
Journal:  Front Physiol       Date:  2012-11-27       Impact factor: 4.566

9.  Docosahexaenoic (DHA) modulates phospholipid-hydroperoxide glutathione peroxidase (Gpx4) gene expression to ensure self-protection from oxidative damage in hippocampal cells.

Authors:  Verónica Casañas-Sánchez; José A Pérez; Noemí Fabelo; David Quinto-Alemany; Mario L Díaz
Journal:  Front Physiol       Date:  2015-07-22       Impact factor: 4.566

10.  Elevation in sphingomyelin synthase activity is associated with increases in amyloid-beta peptide generation.

Authors:  Jen-Hsiang T Hsiao; Yuhong Fu; Andrew F Hill; Glenda M Halliday; Woojin Scott Kim
Journal:  PLoS One       Date:  2013-08-20       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.